EL Ding, Y Song, VS Malik, S Liu - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Inconsistent data ... Cited by 171 - Related articles - BL Direct - All 7 versions
RJ Norman, D Dewailly, RS Legro, TE Hickey - The Lancet, 2007 - Elsevier Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects
about one in 15 women worldwide. The major endocrine disruption is excessive
androgen secretion or activity, and a large proportion of women also have ... Cited by 131 - Related articles - BL Direct - All 19 versions
- ►angrylapdog.com R Pasquali, A Gambineri - European journal of endocrinology, 2006 - eje-online.org.p.angrylapdog.com Insulin-sensitizing agents have been recently proposed as the therapy of choice
for polycystic ovary syndrome (PCOS), since insulin resistance and associated
hyperinsulinemia are recognized as important pathogenetic factors of the ... Cited by 66 - Related articles - BL Direct - All 13 versions
R Pasquali, A Gambineri, U Pagotto - BJOG: An International Journal of Obstetrics & …, 2006 - interscience.wiley.com The polycystic ovary syndrome (PCOS) is one of the most common causes of
infertility due to anovulation in women. The clinical features of PCOS are
heterogeneous and may change throughout the lifespan, starting from ... Cited by 61 - Related articles - All 4 versions
- ►eje-online.org E Carmina, N Napoli, RA Longo, GB Rini, RA … - European Journal of Endocrinology, 2006 - EFES Objective: Metabolic syndrome (MBS) is a common disorder and is thought to be
extremely prevalent in polycystic ovary syndrome (PCOS). In the USA the
prevalence of MBS in PCOS has been reported to be as high as 43–46% using ... Cited by 49 - Related articles - BL Direct - All 8 versions
E Diamanti-Kandarakis, AG Papavassiliou - Trends in molecular medicine, 2006 - Elsevier Polycystic ovary syndrome (PCOS) is a common endocrinopathy of unknown aetiology
that affects women of reproductive age. During the past ten years, defective
insulin activity in PCOS has been demonstrated in target tissues and causes ... Cited by 43 - Related articles - All 7 versions
- ►endojournals.org DM Sloboda, R Hart, DA Doherty, CE Pennell, … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Results: Growth status at birth was judged by expected birth weight ratio (EBW;
a ratio of observed infant's birth weight over median birth weight appropriate
for maternal age, weight, height, parity, infant sex, and gestational age). ... Cited by 34 - Related articles - BL Direct - All 4 versions
- ►endojournals.org R Azziz, E Carmina, D Dewailly, E Diamanti- … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Objective: The Androgen Excess Society (AES) charged a task force to review all
available data and recommend an evidence-based definition for polycystic ovary
syndrome (PCOS), whether already in use or not, to guide clinical diagnosis ... Cited by 36 - Related articles - All 2 versions
- ►angrylapdog.com MA Checa, A Requena, C Salvador, R Tur, J … - Human Reproduction Update, 2005 - humupd.oxfordjournals.org.p.angrylapdog.com Treatment with insulin-sensitizing agents is a relatively recent therapeutic
strategy in women with polycystic ovary syndrome (PCOS) and insulin resistance.
The key areas addressed in this review include PCOS and the development of ... Cited by 33 - Related articles - BL Direct - All 10 versions
